{"log_id": 6536268381394784294, "direction": 0, "words_result_num": 52, "words_result": [{"probability": {"variance": 0.006226, "average": 0.969922, "min": 0.479481}, "location": {"width": 893, "top": 163, "height": 24, "left": 192}, "words": "6%),这主要是由干群体内基因自然表达的改变。对小鼠的两项研究也表明,70倍于人日常临床剂量(0.5g,日服二次)时"}, {"probability": {"variance": 0.008265, "average": 0.973109, "min": 0.352357}, "location": {"width": 895, "top": 190, "height": 23, "left": 190}, "words": "出现上分裂现象(3%~30%),但35倍于人最大日服临床剂量时,无此现象,这一结果提示,其为母子毒性而非致畸性"}, {"probability": {"variance": 0.001192, "average": 0.985378, "min": 0.850851}, "location": {"width": 867, "top": 216, "height": 25, "left": 229}, "words": "怀孕20天后,给予猴10倍于人日常临床较高剂量(0.5g,日服二次)的克拉霉素,会导致流产。这主要是由极高剂量"}, {"probability": {"variance": 0.001426, "average": 0.988669, "min": 0.762462}, "location": {"width": 746, "top": 243, "height": 24, "left": 189}, "words": "的药物毒性所致。在一项补充实验中,给予猴2.5~5倍于最大日常剂量的克拉霉素,没有危及胚胎"}, {"probability": {"variance": 0.008229, "average": 0.964415, "min": 0.505043}, "location": {"width": 854, "top": 270, "height": 26, "left": 229}, "words": "小鼠支配致死实验(lg/kg/天剂量,约70倍于人最大日服临床剂量)中,致突变结果为阴性,而且,大鼠1期实验中"}, {"probability": {"variance": 0.004679, "average": 0.979724, "min": 0.545486}, "location": {"width": 887, "top": 298, "height": 23, "left": 195}, "words": "5g/kg/天剂量(约35倍于人最大日服临床剂量)给药80天,未发现雄性大鼠因长期服用高剂量克拉霉素出现性功能损伤"}, {"probability": {"variance": 0.000101, "average": 0.990041, "min": 0.975941}, "location": {"width": 50, "top": 327, "height": 20, "left": 188}, "words": "致突变"}, {"probability": {"variance": 0.001581, "average": 0.985836, "min": 0.794846}, "location": {"width": 867, "top": 352, "height": 26, "left": 229}, "words": "为评价克拉霉素的致突变能力,进行了非活性和大鼠肝微粒体活性实验系统(Ames实验)。结果表明,药物浓度为每"}, {"probability": {"variance": 0.00443, "average": 0.980474, "min": 0.613426}, "location": {"width": 610, "top": 379, "height": 23, "left": 188}, "words": "碟25mcg或更低时,无致突变能力,浓度为50mcg时,对所有实验菌株产生毒性"}, {"probability": {"variance": 1e-06, "average": 0.999081, "min": 0.99688}, "location": {"width": 99, "top": 406, "height": 23, "left": 195}, "words": "【药代动力学"}, {"probability": {"variance": 0.003269, "average": 0.984123, "min": 0.599493}, "location": {"width": 874, "top": 432, "height": 27, "left": 223}, "words": "克拉霉素缓释片的动力学研究与0.25g和0.5g克拉霉素片的动力学比较研究表明:当每日总剂量相同时,吸收程度也"}, {"probability": {"variance": 0.001482, "average": 0.985538, "min": 0.771474}, "location": {"width": 906, "top": 460, "height": 24, "left": 189}, "words": "相同。克拉霉素缓释片的绝对生物利用度(口服与静脉注射比较)接近50%在多次给药后并未发现累积,也未见任何种属"}, {"probability": {"variance": 6e-05, "average": 0.995479, "min": 0.97672}, "location": {"width": 115, "top": 489, "height": 20, "left": 192}, "words": "代谢倾向的改变"}, {"probability": {"variance": 0.005141, "average": 0.968436, "min": 0.611826}, "location": {"width": 867, "top": 513, "height": 26, "left": 228}, "words": "体外:体外研究的结果表明在浓度为0.45~45mgkg人血浆蛋白结合率平均为70%。当浓度达到45.0m/ml时结合"}, {"probability": {"variance": 0.006805, "average": 0.977011, "min": 0.512387}, "location": {"width": 656, "top": 540, "height": 24, "left": 188}, "words": "率降至41%,表示结合位点可能趋于饱和,但这仅发生在浓度远高于治疗药物有效浓度"}, {"probability": {"variance": 0.005858, "average": 0.977, "min": 0.477801}, "location": {"width": 866, "top": 565, "height": 29, "left": 230}, "words": "克拉霉素的药代动力学行为并非是直线式。对进食患者,每目子0.5g克拉霉素缓释片,克拉霉素和14羟基克拉霉素"}, {"probability": {"variance": 0.005804, "average": 0.972232, "min": 0.497088}, "location": {"width": 910, "top": 593, "height": 26, "left": 187}, "words": "的峰稳定血浆浓度分别为1.3和0.48mg/ml.当每日剂量增至1g时,稳定状态值分别为2.4mg/ml和0.67mg/ml。母药(指克"}, {"probability": {"variance": 0.014268, "average": 0.966145, "min": 0.373856}, "location": {"width": 910, "top": 618, "height": 28, "left": 186}, "words": "拉霉素)与代谢物的消除半衰期(tp)分别近似53和77小时。克拉霉素和它的羟基代谢物在高剂量时,其半衰期明显延"}, {"probability": {"variance": 0, "average": 0.995596, "min": 0.995596}, "location": {"width": 24, "top": 649, "height": 22, "left": 186}, "words": "长"}, {"probability": {"variance": 0.001692, "average": 0.982886, "min": 0.826469}, "location": {"width": 491, "top": 675, "height": 25, "left": 226}, "words": "随尿排出的大约为克拉霉素剂量的40%,随粪便排出的大约占30"}, {"probability": {"variance": 2.5e-05, "average": 0.992571, "min": 0.987552}, "location": {"width": 36, "top": 703, "height": 22, "left": 187}, "words": "患者"}, {"probability": {"variance": 0.000365, "average": 0.992854, "min": 0.881666}, "location": {"width": 852, "top": 731, "height": 24, "left": 229}, "words": "克拉霉素及其14羟基代谢物极易在组织和体液中分布。从少量患者中得到的有限资料显示,克拉霉素口服给药后"}, {"probability": {"variance": 0.001069, "average": 0.988064, "min": 0.823975}, "location": {"width": 905, "top": 757, "height": 27, "left": 191}, "words": "在脑脊液(CS)中未达到有效的浓度(即,血脑脊液屏障正常的患者的CSF药物浓度只达血清浓度的1%~2%)。组织中的"}, {"probability": {"variance": 0.000375, "average": 0.992716, "min": 0.926182}, "location": {"width": 224, "top": 786, "height": 23, "left": 185}, "words": "药物浓度通常较血清中高数倍"}, {"probability": {"variance": 5.9e-05, "average": 0.995587, "min": 0.97866}, "location": {"width": 102, "top": 815, "height": 20, "left": 188}, "words": "肝功能不全者"}, {"probability": {"variance": 0.000746, "average": 0.989522, "min": 0.817065}, "location": {"width": 857, "top": 836, "height": 34, "left": 242}, "words": "项研究对一组健康受试者和一组肝功能不全受试者进行了比较,前两天服用克拉霉素片0.25g,每日2次,第3天"}, {"probability": {"variance": 0.000325, "average": 0.992617, "min": 0.90419}, "location": {"width": 907, "top": 865, "height": 26, "left": 187}, "words": "单次服用0.25g,结果两组受试者的克拉霉素稳态血浆浓度和系统清除无显著差异。相反,肝功能不全受试者的14羟基克"}, {"probability": {"variance": 0.000989, "average": 0.987944, "min": 0.850568}, "location": {"width": 909, "top": 894, "height": 25, "left": 186}, "words": "拉霉素的浓度显著较低。母体化合物14羟基化代谢清除的降低由母体药物肾清除的增加而被部分抵消,因此肝功能不全"}, {"probability": {"variance": 0.005518, "average": 0.98329, "min": 0.502466}, "location": {"width": 907, "top": 920, "height": 25, "left": 187}, "words": "受试者和健康受试者具有相当的母体药物稳态血浆浓度。这些结果提示肝功能中度或重度受损而肾功能正常的患者无需进"}, {"probability": {"variance": 0.000342, "average": 0.98706, "min": 0.951616}, "location": {"width": 85, "top": 948, "height": 23, "left": 187}, "words": "行剂量调整"}, {"probability": {"variance": 6.2e-05, "average": 0.995164, "min": 0.977718}, "location": {"width": 103, "top": 977, "height": 22, "left": 186}, "words": "肾功能不全者"}, {"probability": {"variance": 0.023134, "average": 0.892047, "min": 0.676949}, "location": {"width": 129, "top": 955, "height": 51, "left": 904}, "words": "限公分"}, {"probability": {"variance": 0.001826, "average": 0.984737, "min": 0.737554}, "location": {"width": 871, "top": 1002, "height": 28, "left": 225}, "words": "研究者进行了一项试验,以评估和比较肾功能正常和肾功能下降的受试者多次口服克拉霉素片0.5g后的药物动力学"}, {"probability": {"variance": 0.019325, "average": 0.927069, "min": 0.383473}, "location": {"width": 910, "top": 1030, "height": 26, "left": 185}, "words": "情况。结果,肾功能不全者的克拉霉素及其14羟基代谢物的血浆浓度、半衰期、Cm和C较高,AUC更大。Kctm和"}, {"probability": {"variance": 0.010924, "average": 0.967435, "min": 0.447829}, "location": {"width": 884, "top": 1058, "height": 26, "left": 185}, "words": "排泄较低。这些参数的差异程度与肾功能的损害程度相关;肾功能损害越严重,差异越显著(见【禁忌】【用法用量】)"}, {"probability": {"variance": 0.00049, "average": 0.975041, "min": 0.941075}, "location": {"width": 93, "top": 1087, "height": 22, "left": 189}, "words": "【贮藏】"}, {"probability": {"variance": 0.000416, "average": 0.990543, "min": 0.923625}, "location": {"width": 245, "top": 1113, "height": 24, "left": 220}, "words": "在室温(10~30℃)干燥处保存"}, {"probability": {"variance": 6e-06, "average": 0.997454, "min": 0.994031}, "location": {"width": 95, "top": 1140, "height": 22, "left": 190}, "words": "【包装】"}, {"probability": {"variance": 0.00398, "average": 0.959118, "min": 0.791091}, "location": {"width": 256, "top": 1167, "height": 24, "left": 218}, "words": "铝塑包装,3片/板/盒,7片/板/盒"}, {"probability": {"variance": 3e-06, "average": 0.99823, "min": 0.995916}, "location": {"width": 95, "top": 1195, "height": 24, "left": 190}, "words": "【有效期】"}, {"probability": {"variance": 3e-06, "average": 0.998291, "min": 0.994873}, "location": {"width": 97, "top": 1223, "height": 23, "left": 219}, "words": "暂定24个月"}, {"probability": {"variance": 7.3e-05, "average": 0.994292, "min": 0.976904}, "location": {"width": 91, "top": 1250, "height": 22, "left": 189}, "words": "【执行标准】"}, {"probability": {"variance": 0.007302, "average": 0.964894, "min": 0.696301}, "location": {"width": 101, "top": 1281, "height": 18, "left": 223}, "words": "YBH06702003"}, {"probability": {"variance": 0.00059, "average": 0.979367, "min": 0.940778}, "location": {"width": 91, "top": 1305, "height": 23, "left": 191}, "words": "【批准文号】"}, {"probability": {"variance": 0.015156, "average": 0.958419, "min": 0.532346}, "location": {"width": 154, "top": 1335, "height": 20, "left": 219}, "words": "国药准字H20031041"}, {"probability": {"variance": 9e-06, "average": 0.997171, "min": 0.990916}, "location": {"width": 91, "top": 1361, "height": 22, "left": 191}, "words": "【生产企业】"}, {"probability": {"variance": 0.000129, "average": 0.993941, "min": 0.959937}, "location": {"width": 294, "top": 1389, "height": 23, "left": 220}, "words": "企业名称:江苏恒瑞医药股份有限公司"}, {"probability": {"variance": 0.001544, "average": 0.99054, "min": 0.814852}, "location": {"width": 357, "top": 1416, "height": 22, "left": 219}, "words": "生产地址:连云港经济技术开发区黄河路38号"}, {"probability": {"variance": 0.000218, "average": 0.990264, "min": 0.954407}, "location": {"width": 137, "top": 1445, "height": 20, "left": 220}, "words": "邮政编码:222047"}, {"probability": {"variance": 0.009519, "average": 0.96714, "min": 0.48636}, "location": {"width": 289, "top": 1473, "height": 21, "left": 218}, "words": "电话号码:800-8283900400-8283900"}, {"probability": {"variance": 0.006594, "average": 0.974289, "min": 0.642346}, "location": {"width": 193, "top": 1501, "height": 21, "left": 217}, "words": "传真号码:0518-85463261"}, {"probability": {"variance": 0.011418, "average": 0.942133, "min": 0.528586}, "location": {"width": 311, "top": 1528, "height": 24, "left": 218}, "words": "网址:http:/ www hrs.com..cn"}], "language": 3}